Roles of lactoferrin on skin wound healing

Biochemistry and Cell Biology

Volumn 90, Issue 3, 2012, Pages 497-503

  Takayama, Yoshiharu ^a   Aoki, Reiji ^a  

^a NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

Author keywords

Collagen; Fibroblasts; Inflammation; Keratinocytes; Wound contraction

Indexed keywords

ANTI-INFLAMMATORY ACTIVITY; BIOLOGICAL PROCESS; CELL TYPES; CHRONIC WOUNDS; COLLAGEN GELS; EPITHELIAL CELLS; EXTRACELLULAR MATRIX COMPONENTS; HYALURONAN; IMMUNE CELLS; IMMUNE RESPONSE; IN-VITRO; INFLAMMATION; IRON BINDING; KERATINOCYTES; LACTOFERRIN; RE-EPITHELIALIZATION; TISSUE FORMATION; WOUND CONTRACTION; WOUND HEALING;

COLLAGEN; ENDOTHELIAL CELLS; FIBROBLASTS; GRANULATION; PATHOLOGY; TISSUE;

CELL CULTURE;

COLLAGEN; COLLAGEN GEL; CYTOKINE; HYALURONIC ACID; LACTOFERRIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; TALACTOFERRIN; XYLITOL;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DIABETIC FOOT; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIZATION; EXTRACELLULAR MATRIX; GRANULATION TISSUE; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; KERATINOCYTE; NONHUMAN; PERIPHERAL NEUROPATHY; PHAGOCYTOSIS; PROTEIN FUNCTION; REEPITHELIALIZATION; REVIEW; SKIN FIBROBLAST; SKIN INFLAMMATION; SKIN INJURY; WOUND CONTRACTION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; CELL ADHESION; CELL MOVEMENT; DERMATITIS; HUMANS; LACTOFERRIN; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; SKIN PHYSIOLOGICAL PROCESSES; WOUND HEALING;

EID: 84861408298     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o11-054     Document Type: Review

References (70)

1. Actor J.K. Hwang S.A. Kruzel M.L. 2009. Lactoferrin as a natural immune modulator. Curr. Pharm. Des. 15 (17): 1956-1973. 10.2174/138161209788453202 19519436
2. Almond A. 2007. Hyaluronan. Cell. Mol. Life Sci. 64 (13): 1591-1596. 10.1007/s00018-007-7032-z 17502996
3. Ambruso D.R. Johnston R.B. Jr. 1981. Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J. Clin. Invest. 67 (2): 352-360. 10.1172/JCI110042 6780607
4. Ammons M.C. Ward L.S. James G.A. 2011. Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings. Int. Wound J. 8 (3): 268-273. 10.1111/j.1742-481X.2011.00781.x 21457463
5. Ashby B. Garrett Q. Willcox M. 2011. Bovine lactoferrin structures promoting corneal epithelial wound healing in vitro. Invest. Ophthalmol. Vis. Sci. 52 (5): 2719-2726. 10.1167/iovs.10-6352 21282581
6. Biet F. Locht C. Kremer L. 2002. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J. Mol. Med. 80 (3): 147-162. 10.1007/s00109-001-0307-1 11894141
7. Brock J.H. 2002. The physiology of lactoferrin. Biochem. Cell Biol. 80 (1): 1-6. 10.1139/o01-212 11908632
8. Conneely O.M. 2001. Antiinflammatory activities of lactoferrin. J. Am. Coll. Nutr. 20 (5): 389S-395S, discussion 396S-397S. 11603648
9. Cumberbatch M. Gould S.J. Peters S.W. Basketter D.A. Dearman R.J. Kimber I. 1992. Langerhans cells, antigen presentation, and the diversity of responses to chemical allergens. J. Invest. Dermatol. 99 (5): 107S-108S. 10.1111/1523-1747.ep12669992 1431198
10. Cumberbatch M. Dearman R.J. Kimber I. 1997. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 β for migration. Immunology, 92 (3): 388-395. 10.1046/j.1365-2567.1997.00360.x 9486113
11. Cumberbatch M. Dearman R.J. Uribe-Luna S. Headon D.R. Ward P.P. Conneely O.M. Kimber I. 2000. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology, 100 (1): 21-28. 10.1046/j.1365-2567.2000.00014.x 10809955
12. Eming S.A. Krieg T. Davidson J.M. 2007. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127 (3): 514-525. 10.1038/sj.jid.5700701 17299434
13. Engelmayer J. Blezinger P. Varadhachary A. 2008. Talactoferrin stimulates wound healing with modulation of inflammation. J. Surg. Res. 149 (2): 278-286. 10.1016/j.jss.2007.12.754 18619616
14. Fischer R. Debbabi H. Dubarry M. Boyaka P. Tome D. 2006. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem. Cell Biol. 84 (3): 303-311. 10.1139/o06-058 16936801
15. Frank S. Madlener M. Werner S. 1996. Transforming growth factors β1, β2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271 (17): 10188-10193. 10.1074/jbc.271.17.10188 8626581
16. Gæde P. Vedel P. Larsen N. Jensen G.V. Parving H.H. Pedersen O. 2003. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (5): 383-393. 10.1056/NEJMoa021778 12556541
17. Grey A. Banovic T. Zhu Q. Watson M. Callon K. Palmano K. et al. 2004. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 18 (9): 2268-2278. 10.1210/me.2003-0456 15178744
18. Grinnell F. 1994. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124 (4): 401-404. 10.1083/jcb.124.4.401 8106541
19. Grinnell F. Petroll W.M. 2010. Cell motility and mechanics in three-dimensional collagen matrices. Annu. Rev. Cell Dev. Biol. 26 (1): 335-361. 10.1146/annurev.cellbio.042308.113318 19575667
20. Grinnell F. Ho C.H. Lin Y.C. Skuta G. 1999. Differences in the regulation of fibroblast contraction of floating versus stressed collagen matrices. J. Biol. Chem. 274 (2): 918-923. 10.1074/jbc.274.2.918 9873032
21. Guillén C. McInnes I.B. Vaughan D.M. Kommajosyula S. Van Berkel P.H. Leung B.P. et al. 2002. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol. 168 (8): 3950-3957. 11937551
22. Heldin C.H. Westermark B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79 (4): 1283-1316. 10508235
23. Herrick S.E. Ireland G.W. Simon D. McCollum C.N. Ferguson M.W. 1996. Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. J. Invest. Dermatol. 106 (1): 187-193. 10.1111/1523-1747.ep12329920 8592073
24. Herz J. Strickland D.K. 2001. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108 (6): 779-784. 10.1172/JCI13992 11560943
25. Kämpfer H. Kalina U. Muhl H. Pfeilschifter J. Frank S. 1999. Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J. Invest. Dermatol. 113 (3): 369 - 374. 10.1046/j.1523-1747.1999.00704.x 10469336
26. Kämpfer H. Muhl H. Manderscheid M. Kalina U. Kauschat D. Pfeilschifter J. Frank S. 2000 a. Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing. Eur. Cytokine Netw. 11 (4): 626 - 633. 11125306
27. Kämpfer H. Paulukat J. Muhl H. Wetzler C. Pfeilschifter J. Frank S. 2000 b. Lack of interferon-γ production despite the presence of interleukin-18 during cutaneous wound healing. Mol. Med. 6 (12): 1016 - 1027. 11474118
28. Kim C.W. Son K.N. Choi S.Y. Kim J. 2006. Human lactoferrin upregulates expression of KDR/Flk-1 and stimulates VEGF-A-mediated endothelial cell proliferation and migration. FEBS Lett. 580 (18): 4332-4336. 10.1016/j.febslet.2006.06.091 16842782
29. Kinnaird A. Peters S.W. Foster J.R. Kimber I. 1989. Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int. Arch. Allergy Appl. Immunol. 89 (2-3): 202-210. 10.1159/000234947 2759716
30. Kondo T. Ohshima T. Mori R. Guan D.W. Ohshima K. Eisenmenger W. 2002. Immunohistochemical detection of chemokines in human skin wounds and its application to wound age determination. Int. J. Legal Med. 116 (2): 87-91. 10.1007/s004140100260 12056526
31. Kuhara T. Iigo M. Itoh T. Ushida Y. Sekine K. Terada N. et al. 2000. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr. Cancer, 38 (2): 192-199. 10.1207/S15327914NC382-8 11525597
32. Lee J.M. Dedhar S. Kalluri R. Thompson E.W. 2006. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172 (7): 973-981. 10.1083/jcb.200601018 16567498
33. LeFrock J.L. Joseph W.S. 1995. Bone and soft-tissue infections of the lower extremity in diabetics. Clin. Podiatr. Med. Surg. 12 (1): 87-103. 7720035
34. Legrand D. Elass E. Carpentier M. Mazurier J. 2005. Lactoferrin: a modulator of immune and inflammatory responses. Cell. Mol. Life Sci. 62 (22): 2549-2559. 10.1007/s00018-005-5370-2 16261255
35. Li J. Zhang Y.P. Kirsner R.S. 2003. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60 (1): 107-114. 10.1002/jemt.10249 12500267
36. Lin Z.Q. Kondo T. Ishida Y. Takayasu T. Mukaida N. 2003. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J. Leukoc. Biol. 73 (6): 713-721. 10.1189/jlb.0802397 12773503
37. Loots M.A. Lamme E.N. Zeegelaar J. Mekkes J.R. Bos J.D. Middelkoop E. 1998. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J. Invest. Dermatol. 111 (5): 850-857. 10.1046/j.1523-1747.1998.00381.x 9804349
38. Lyons T.E. Miller M.S. Serena T. Sheehan P. Lavery L. Kirsner R.S. et al. 2007. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am. J. Surg. 193 (1): 49-54. 10.1016/j.amjsurg.2006.07.010 17188087
39. Mader J.S. Smyth D. Marshall J. Hoskin D.W. 2006. Bovine lactoferricin inhibits basic fibroblast growth factor-and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. Am. J. Pathol. 169 (5): 1753-1766. 10.2353/ajpath.2006.051229 17071598
40. Martin P. 1997. Wound healing'aiming for perfect skin regeneration. Science, 276 (5309): 75-81. 10.1126/science.276.5309.75 9082989
41. Mast B.A. Diegelmann R.F. Krummel T.M. Cohen I.K. 1993. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix, 13 (6): 441-446. 8309423
42. Norrby K. 2004. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo. J. Vasc. Res. 41 (4): 293-304. 10.1159/000078927 15192265
43. Norrby K. Mattsby-Baltzer I. Innocenti M. Tuneberg S. 2001. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int. J. Cancer, 91 (2): 236-240. 10.1002/1097- 0215(200002)9999:9999<::AID-IJC1024>3.3.CO;2-K 11146451
44. Pattamatta U. Willcox M. Stapleton F. Cole N. Garrett Q. 2009. Bovine lactoferrin stimulates human corneal epithelial alkali wound healing in vitro. Invest. Ophthalmol. Vis. Sci. 50 (4): 1636-1643. 10.1167/iovs.08-1882 19060270
45. Pellegrin S. Mellor H. 2007. Actin stress fibres. J. Cell Sci. 120 (20): 3491-3499. 10.1242/jcs.018473 17928305
46. Pöllänen M.T. Hkkinen L. Overman D.O. Salonen J.I. 1998. Lactoferrin impedes epithelial cell adhesion in vitro. J. Periodontal Res. 33 (1): 8 - 16. 10.1111/j.1600-0765.1998.tb02286.x 9524316
47. Raja Sivamani K. Garcia M.S. Isseroff R.R. 2007. Wound re-epithelialization: modulating keratinocyte migrationin wound healing. Front. Biosci. 12 (8-12): 2849-2868. 10.2741/2277 17485264
48. Roberts A.B. Sporn M.B. Assoian R.K. Smith J.M. Roche N.S. Wakefield L.M. et al. 1986. Transforming growth factor type betaβ: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83 (12): 4167-4171. 10.1073/pnas.83.12.4167 2424019
49. Robson M.C. 1997. The role of growth factors in the healing of chronic wounds. Wound Repair Regen. 5 (1): 12-17. 10.1046/j.1524-475X.1997.50106.x 16984452
50. Saito S. Takayama Y. Mizumachi K. Suzuki C. 2011. Lactoferrin promotes hyaluronan synthesis in human dermal fibroblasts. Biotechnol. Lett. 33 (1): 33-39. 10.1007/s10529-010-0389-3 20820878
51. Sakamoto K. Ito Y. Mori T. Sugimura K. 2006. Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopes. J. Biol. Chem. 281 (34): 24472-24478. 10.1074/jbc.M604974200 16787913
52. Sharma G.D. He J.C. Bazan H.E.P. 2002. Hepatocyte (HGF) and keratinocyte growth factor (KGF) differentially regulate MAP-kinases (Erk 1/2, P38 and JNK): evidence of a cross-talk between Erk1/2 and P38 in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 43: U360-U360.
53. Shau H. Kim A. Golub S.H. 1992. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukoc. Biol. 51 (4): 343-349. 1564398
54. Shaw T.J. Martin P. 2009. Wound repair at a glance. J. Cell Sci. 122 (18): 3209-3213. 10.1242/jcs.031187 19726630
55. Shimamura M. Yamamoto Y. Ashino H. Oikawa T. Hazato T. Tsuda H. Iigo M. 2004. Bovine lactoferrin inhibits tumor-induced angiogenesis. Int. J. Cancer, 111 (1): 111-116. 10.1002/ijc.20187 15185351
56. Shinmoto H. Sato K. Dosako S. 1992. Inhibition by bovine lactoferrin of adhesion of L929 cells cultured in serum-free git medium. Biosci. Biotechnol. Biochem. 56 (6): 965-966. 10.1271/bbb.56.965
57. Singer A.J. Clark R.A. 1999. Cutaneous wound healing. N. Engl. J. Med. 341 (10): 738-746. 10.1056/NEJM199909023411006 10471461
58. Soneja A. Drews M. Malinski T. 2005. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol. Rep. 57 (Suppl): 108-119. 16415491
59. Spadaro M. Caorsi C. Ceruti P. Varadhachary A. Forni G. Pericle F. Giovarelli M. 2008. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J. 22 (8): 2747-2757. 10.1096/fj.07-098038 18364398
60. Stern R. 2003. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology, 13 (12): 105R-115R. 10.1093/glycob/cwg112 14514708
61. Takayama Y. Mizumachi K. 2001. Effects of lactoferrin on collagen gel contractile activity and myosin light chain phosphorylation in human fibroblasts. FEBS Lett. 508 (1): 111-116. 10.1016/S0014-5793(01)03041-1 11707279
62. Takayama Y. Mizumachi K. Takezawa T. 2002. The bovine lactoferrin region responsible for promoting the collagen gel contractile activity of human fibroblasts. Biochem. Biophys. Res. Commun. 299 (5): 813-817. 10.1016/S0006-291X(02)02748-1 12470651
63. Takayama Y. Takahashi H. Mizumachi K. Takezawa T. 2003. Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J. Biol. Chem. 278 (24): 22112-22118. 10.1074/jbc.M300894200 12672816
64. Tang L. Cui T. Wu J.J. Liu-Mares W. Huang N. Li J. 2010 a. A rice-derived recombinant human lactoferrin stimulates fibroblast proliferation, migration, and sustains cell survival. Wound Repair Regen. 18 (1): 123-131. 10.1111/j.1524-475X.2009.00563.x 20082685
65. Tang L. Wu J.J. Ma Q. Cui T. Andreopoulos F.M. Gil J. et al. 2010 b. Human lactoferrin stimulates skin keratinocyte function and wound re-epithelialization. Br. J. Dermatol. 163 (1): 38-47. 20222924
66. Tonnesen M.G. Feng X. Clark R.A. 2000. Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc. 5 (1): 40-46. 10.1046/j.1087-0024.2000.00014.x 11147674
67. Toole B.P. 2000. Hyaluronan is not just a goo! J. Clin. Invest. 106 (3): 335-336. 10.1172/JCI10706 10930435
68. Ward P.P. Uribe-Luna S. Conneely O.M. 2002. Lactoferrin and host defense. Biochem. Cell Biol. 80 (1): 95-102. 10.1139/o01-214 11908649
69. Werner S. Grose R. 2003. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83 (3): 835-870. 12843410
70. Zweiman B. Kucich U. Shalit M. Von Allmen C. Moskovitz A. Weinbaum G. Atkins P.C. 1990. Release of lactoferrin and elastase in human allergic skin reactions. J. Immunol. 144 (10): 3953-3960. 1692068